The single biggest signal this week is a fresh surge in weight-loss demand: Zepbound tops the Emerging Demand Index at 2.14, driven by a 47% week-over-week jump in Wikipedia pageviews. That's the largest consumer-attention delta in the index and lands during a quiet respiratory week, making it the story operators should build capacity around.

Emerging Demand — What to Watch

  • Zepbound — EDI 2.14 (Weight Loss). Wikipedia pageviews +47% WoW. No new FDA action this week, so this is pure consumer curiosity — likely downstream of continued payer-coverage debates and off-label chatter. Expect intake-form spikes at med-spa and weight-loss clinics within 2-3 weeks.
  • Thyroid nodule — EDI 1.12 (Endocrinology). Wikipedia pageviews +28% WoW. Nodule searches often follow GLP-1 side-effect coverage; endocrinology schedulers should watch for a bump in ultrasound referrals.
  • Sciatica — EDI 1.07 (Orthopedics, Pain Management). Wikipedia pageviews +27% WoW. Consistent with mid-summer activity-related back complaints — a classic leading indicator for ortho and PM&R self-referrals.
  • PCOS — EDI 0.91 (Endocrinology, Women's Health). Wikipedia pageviews +24% WoW. PCOS interest is increasingly coupled to GLP-1 conversation; women's health clinics offering metabolic workups are the natural landing spot.
  • IVF — EDI 0.91 (Fertility). Wikipedia pageviews +24% WoW. Attention is broad-based, not tied to a specific news event — likely a seasonal planning cycle as families weigh Q4 treatment starts.

Just outside the top 5: depression (EDI 0.83) and anxiety (EDI 0.71) are notable because both are corroborated by clinical-trial pipelines — 37 new recruiting depression trials and 42 new anxiety trials in the last 30 days, on top of Wikipedia gains of +19% and +15% respectively. That's a two-source signal, which is stronger than the wiki-only leaders.

Search Intent

Google Trends returned no notable rising or falling national conditions this week, which is unusual and suggests search intent is diffuse rather than concentrated. That neither confirms nor contradicts the EDI view — but it does mean the Wikipedia-driven signals above aren't being echoed in high-volume Google queries yet, so operators have a short window to get ahead of demand before it shows up in paid-search auctions.

Structural Markets

Arkansas remains the most structurally elevated state in the country, running 8.5 points above the national average on high blood pressure (42.5% vs 34%), 4.6 points above on obesity (38.9% vs 34.3%), 3.4 points above on depression, and 3.3 points above on COPD. Any multi-condition primary care or cardiometabolic operator underweight in Arkansas is leaving demand on the table. Michigan and Ohio are the depression story this week, at 26.7% and 26.6% prevalence respectively — both roughly 5 points above the 21.7% national rate — which pairs cleanly with the depression EDI signal for behavioral health operators considering Midwest expansion.

Respiratory Watch

COVID is rising in Texas (65 of 65 HSAs reporting rising) and Georgia (14 of 14 HSAs rising) as of the week ending 2026-07-18. This is a broad-based summer wave in the South, not a localized cluster. RSV is falling in New York, Michigan, and Texas — consistent with normal seasonality. Urgent care and telehealth operators in TX and GA metros should staff for a 2-4 week COVID bump; no action needed on RSV.

The Bottom Line

Lean into the GLP-1 halo: Zepbound, PCOS, and thyroid-nodule searches are all rising together, which means weight-loss, endocrinology, and women's health clinics should coordinate intake and cross-referral this month rather than treating them as separate funnels. In parallel, Texas and Georgia urgent care operators should pre-stage COVID capacity, and behavioral health groups eyeing the Midwest have a clean two-source case for Michigan and Ohio expansion.